Virtual Library

Start Your Search

Y. Ren

Author of

  • +

    Poster Session (ID 8)

    • Event: ACLC 2018
    • Type: Poster Session
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 11/07/2018, 00:00 - 00:00, Poster Hall
    • +

      P024 - Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Experience of a Single Institute (ID 111)

      00:00 - 00:00  |  Author(s): Y. Ren

      • Abstract

      To evaluate the feasibility and safety of sleeve lobectomy for centrally located non-small cell lung cancer and summarize our surgical experience.

      Clinical data of 45 patients who underwent sleeve lobectomy at Department of Thoracic Surgery of Liaoning Cancer Hospital & Institute from November 2016 to June 2018 including 6 cases had neoadjuvant chemotherapy were collected retrospectively, and operative strategies, time of postoperative drainage, postoperative hospital stay and postoperative complications were also recorded.

      All patients received sleeve lobectomy successfully. Of all the patients, 8 patients underwent bronchial and arterial sleeve lobectomy, 4 underwent bronchial sleeve resection and partial side wall of arterial resection, 2 underwent arterial sleeve resection and partial side wall of bronchial resection, 31 underwent bronchial sleeve resection only. There was no perioperative death in all patients. Margin status was R0 in 39 patients (86.7%), R1 in 5 patients (11.1%), R2 in 1 patient (2.2%). The median time of postoperative drainage was 7 days (3-26 days), median time of postoperative hospital stay was 11 days (6-28 days). Major complications occurred in 11 patients (24.4%), including 1 chylothorax, 6 pneumonia, 3 pleural effusion, 1 air leak. Endotracheal endoscopic sputum aspiration was performed in 11 patients postoperatively. Pathologic diagnosis showed squamous cell carcinoma in 35 patients, adenocarcinoma in 6 patients, adenosquamous carcinoma in 2 patients, and large cell carcinoma in 1 patient. 2 patients were in stage ?A3, 7 patients were in stage ?B, 2 patients were in stage ?A, 24 patients were in stage ?B, 5 patients were in stage ?A?and 4 patients were in stage ?B. All patients recovered well and were discharged uneventfully.

      Sleeve lobectomy is a safe and feasible procedure for treatment of centrally located non-small-cell lung cancer. It is an accepted procedure to expand operation indications and avoid pneumonectomy, improve postoperative quality of life.